Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
NICE technology appraisal TA875 (2023) recommends semaglutide 2.4 mg (Wegovy) as an adjunct to a reduced-calorie diet and increased physical activity for adults with a BMI of 35 kg/m or above (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when initiated within specialist weight management services
Fuel your burn
Product-specific sterility, endotoxin, bioavailability, and long-term stability also require separate evidence
Accounting for Vial Overfill Manufacturers intentionally overfill lyophilized peptide vials by 515% to account for powder adhesion to glass walls and residual loss during reconstitution
Injection bypasses first-pass hepatic metabolism and gastrointestinal absorption variability, potentially achieving higher bioavailability
US$ 21.96
US$ 26.60
US$ 25.66
US$ 29.13
US$ 20.10
